Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103665038B enables room temperature synthesis of high-purity chiral phosphine oxides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110004081A details a novel biocatalytic route for gamma-lactam. This method ensures high optical purity and offers significant supply chain cost reduction advantages.
Patent CN102161978B reveals a green Rhodococcus strain for Cilastatin intermediates. Achieve high optical purity with reduced environmental impact and lower manufacturing costs.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN116396950B reveals novel carboxylesterase mutants for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN103998618A reveals enzymatic hydrolysis for high-purity chiral intermediates. Discover supply chain advantages and cost reduction strategies.